card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Companion Diagnostic Development: Current trends and recommendations

Home / Insights / Companion Diagnostic Development: Current trends and recommendations

Examining the trends in personalized medicine sheds light on ways to create successful partnerships between sponsors, laboratories, and manufacturers of in-vitro diagnostic products (IVDs) to develop more efficiently stand-alone diagnostics, companion diagnostics (CDx), and complementary diagnostics. This is particularly relevant in light of the paradigm shift on the horizon for developing and ensuring reimbursement of such personalized medicine solutions with new technologies. Download this insight brief now to learn six strategies for success when developing your companion diagnostic.

Authors:
Patrice Hugo, PhD, Chief Scientific Officer
Richard Heichemer, MS, MBA, Scientific Advisor, Companion Diagnostics

Complete the form below to access this insight brief